Effects of a Secondary Prevention Combination Therapy with beta-Blocker and Statin on Major Adverse Cardiovascular Events in Acute Coronary Syndrome Patients.

CONCLUSIONS Beta-blocker and statin combination therapy lowered the risk of developing MACE in ACS patients. PMID: 32808600 [PubMed - in process]
Source: Medical Science Monitor - Category: Research Tags: Med Sci Monit Source Type: research